Application of circulating free DNA in the diagnosis and treatment of hepatocellular carcinoma / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 2835-2838, 2020.
Article
in Zh
| WPRIM
| ID: wpr-837660
Responsible library:
WPRO
ABSTRACT
Hepatocellular carcinoma has a low early diagnostic rate, and there is a lack of highly sensitive and specific tumor markers. In recent years, fluid biopsy technique, represented by circulating free DNA (cfDNA), has become an auxiliary method for the diagnosis of cancer and has attracted more and more attention due to its advantages of noninvasiveness, convenience, and repeatability. With reference to the recent studies in China and foreign countries, this article summarizes and analyzes the advances in cfDNA in the diagnosis and treatment of hepatocellular carcinoma from the aspects of biological characteristics, detection techniques, and clinical application, so as to provide a basis for clinical diagnosis and treatment.
Full text:
1
Database:
WPRIM
Type of study:
Diagnostic_studies
Language:
Zh
Journal:
Journal of Clinical Hepatology
Year:
2020
Document type:
Article